Proton therapy in Hodgkin Lymphoma yields favourable acute toxicity profile

Hodgkin lymphoma patients treated with consolidative proton therapy after chemotherapy had “excellent” early relapse-free survival rates and no early grade 3 radiotherapy-related toxicities, according to a study published in the Annals of Oncology.
Cancer Network